Equities
Health CareMedical Equipment and Services
  • Price (USD)223.09
  • Today's Change-5.12 / -2.24%
  • Shares traded425.63k
  • 1 Year change+2.67%
  • Beta1.6522
Data delayed at least 15 minutes, as of Nov 22 2024 16:54 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy4
Outperform4
Hold6
Sell1
Strong Sell1

Share price forecast in USD

The 12 analysts offering 12 month price targets for Align Technology, Inc. have a median target of 262.50, with a high estimate of 320.00 and a low estimate of 200.00. The median estimate represents a 15.03% increase from the last price of 228.21.
High40.2%320.00
Med15.0%262.50
Low-12.4%200.00

Earnings history & estimates in USD

On Oct 23, 2024, Align Technology, Inc. reported 3rd quarter 2024 earnings of 2.35 per share. This result was in line with the consensus of the 11 analysts following the company and exceeded last year's 3rd quarter results by 9.81%.
The next earnings announcement is expected on Jan 29, 2025.
Average growth rate+2.91%
Align Technology, Inc. reported annual 2023 earnings of 8.61 per share on Jan 31, 2024.
Average growth rate+22.19%
More ▼

Revenue history & estimates in USD

Align Technology, Inc. had 3rd quarter 2024 revenues of 977.87m. This missed the 987.34m consensus estimate of the 11 analysts following the company. This was 3.68% above the prior year's 3rd quarter results.
Average growth rate+0.52%
Align Technology, Inc. had revenues for the full year 2023 of 3.86bn. This was 3.42% above the prior year's results.
Average growth rate+15.13%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.